Graypoint LLC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Sell |
2,662
-306
| -10% | -$37K | 0.02% | 415 |
|
|
2025
Q1 | $331K | Sell |
2,968
-389
| -12% | -$43.4K | 0.02% | 389 |
|
|
2024
Q4 | $327K | Sell |
3,357
-384
| -10% | -$37.4K | 0.02% | 388 |
|
|
2024
Q3 | $430K | Sell |
3,741
-18
| -0.5% | -$2.07K | 0.03% | 333 |
|
|
2024
Q2 | $400K | Sell |
3,759
-1,909
| -34% | -$203K | 0.03% | 327 |
|
|
2024
Q1 | $548K | Sell |
5,668
-41
| -0.7% | -$3.97K | 0.04% | 262 |
|
|
2023
Q4 | $576K | Sell |
5,709
-1,318
| -19% | -$133K | 0.05% | 233 |
|
|
2023
Q3 | $716K | Sell |
7,027
-255
| -4% | -$26K | 0.07% | 188 |
|
|
2023
Q2 | $735K | Sell |
7,282
-605
| -8% | -$61.1K | 0.07% | 163 |
|
|
2023
Q1 | $726K | Sell |
7,887
-1,599
| -17% | -$147K | 0.08% | 162 |
|
|
2022
Q4 | $861K | Sell |
9,486
-116
| -1% | -$10.5K | 0.1% | 133 |
|
|
2022
Q3 | $730K | Buy |
9,602
+28
| +0.3% | +$2.13K | 0.09% | 149 |
|
|
2022
Q2 | $809K | Sell |
9,574
-132
| -1% | -$11.2K | 0.1% | 137 |
|
|
2022
Q1 | $852K | Sell |
9,706
-45
| -0.5% | -$3.95K | 0.08% | 147 |
|
|
2021
Q4 | $853K | Sell |
9,751
-369
| -4% | -$32.3K | 0.09% | 149 |
|
|
2021
Q3 | $828K | Buy |
10,120
+197
| +2% | +$16.1K | 0.1% | 136 |
|
|
2021
Q2 | $905K | Sell |
9,923
-617
| -6% | -$56.3K | 0.12% | 124 |
|
|
2021
Q1 | $901K | Sell |
10,540
-1,032
| -9% | -$88.2K | 0.14% | 120 |
|
|
2020
Q4 | $1.09M | Sell |
11,572
-2,106
| -15% | -$199K | 0.19% | 100 |
|
|
2020
Q3 | $1.19M | Sell |
13,678
-2,263
| -14% | -$197K | 0.23% | 87 |
|
|
2020
Q2 | $1.39M | Buy |
15,941
+1,096
| +7% | +$95.7K | 0.32% | 74 |
|
|
2020
Q1 | $1.22M | Buy |
+14,845
| New | +$1.22M | 0.34% | 70 |
|